NCT05356910

Brief Summary

Onboarding Positives and PrEP users to Engage Negatives (OPPEN) is an intervention to train young men who have sex with men (YMSM) of color living with HIV or using pre-exposure prophylaxis (PrEP) to promote PrEP use among HIV-negative YMSM of color in their social networks. This pilot randomized controlled trial will evaluate OPPEN's acceptability, feasibility, and preliminary effect on PrEP care engagement among YMSM of color.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
78

participants targeted

Target at P25-P50 for not_applicable hiv

Timeline
Completed

Started Apr 2022

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 7, 2022

Completed
19 days until next milestone

First Submitted

Initial submission to the registry

April 26, 2022

Completed
6 days until next milestone

First Posted

Study publicly available on registry

May 2, 2022

Completed
2.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 31, 2024

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

August 31, 2024

Completed
11 months until next milestone

Results Posted

Study results publicly available

July 23, 2025

Completed
Last Updated

July 23, 2025

Status Verified

July 1, 2025

Enrollment Period

2.3 years

First QC Date

April 26, 2022

Results QC Date

July 2, 2025

Last Update Submit

July 2, 2025

Conditions

Outcome Measures

Primary Outcomes (3)

  • PrEP Interest (Peer-Recruit Participants)

    Participants used 5-point Likert scale responses (very uninterested to very interested) to indicate their interest in taking oral PrEP ("How interested are you in taking oral PrEP to prevent HIV?") and injectable PrEP ("How interested are you in taking injectable PrEP to prevent HIV?"). Responses of "interested" or "very interested" in either oral or injectable PrEP defined PrEP interest.

    Baseline

  • PrEP Linkage (Peer-Recruit Participants)

    Attended a PrEP care visit since baseline.

    3-month follow-up

  • PrEP Uptake (Peer-Recruit Participants)

    Started using oral or injectable PrEP since baseline.

    3-month follow-up

Secondary Outcomes (8)

  • PrEP Conversations With Peers (Index Participants)

    3-month follow-up

  • PrEP Information (Peer-Recruit Participants)

    Baseline

  • PrEP Motivation (Peer-Recruit Participants)

    Baseline

  • PrEP Behavioral Skills (Peer-Recruit Participants)

    Baseline

  • Session Acceptability (Index Participants)

    3-month follow-up

  • +3 more secondary outcomes

Study Arms (2)

OPPEN Intervention

EXPERIMENTAL

OPPEN consists of three small-group and two one-on-one sessions to train YMSM of color engaged in HIV or PrEP care to be peer PrEP educators within their social networks.

Behavioral: OPPEN

Control Condition

OTHER

The time- and attention-matched control condition consists of three small-group and two one-on-one sessions to support diet and nutrition behavior change.

Behavioral: Control Condition

Interventions

OPPENBEHAVIORAL

OPPEN training sessions (three small-group and two one-on-one sessions) build skills for effective peer PrEP outreach through didactic instruction, group discussions, role-play exercises, and goal planning and problem-solving activities.

OPPEN Intervention

Control sessions (three small-group and two one-on-one sessions) build skills for diet and nutrition behavior change through didactic instruction, group discussions, and goal planning and problem-solving activities.

Control Condition

Eligibility Criteria

Age18 Years - 34 Years
Sexmale(Gender-based eligibility)
Gender Eligibility DetailsPersons screened for eligibility will be asked their gender identity. Those who identify as cisgender men will be eligible.
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • years-old
  • Cisgender male
  • Fluent in English
  • Person of color
  • Engaged in HIV care or PrEP care
  • Sexual activity with cisgender men or transgender women in their lifetime
  • Social networks with at least three 18-34 year-old MSM peers of color
  • Willing to disclose their HIV status or PrEP use to their 18-34 year-old MSM peers of color
  • Willing to provide written informed consent
  • years-old
  • Cisgender male
  • Fluent in English or Spanish
  • Person of color
  • HIV-negative
  • Not using PrEP
  • +2 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of California, San Diego

San Diego, California, 92103, United States

Location

Results Point of Contact

Title
Heather Pines
Organization
University of California, San Diego

Study Officials

  • Heather A Pines, PhD

    University of California, San Diego

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

April 26, 2022

First Posted

May 2, 2022

Study Start

April 7, 2022

Primary Completion

July 31, 2024

Study Completion

August 31, 2024

Last Updated

July 23, 2025

Results First Posted

July 23, 2025

Record last verified: 2025-07

Data Sharing

IPD Sharing
Will share

De-identified data will be made available upon review of written requests from researchers.

Shared Documents
STUDY PROTOCOL, SAP, ICF
Time Frame
Approximately 6 months after the publication of the study's primary findings.
Access Criteria
Requests from researchers for de-identified data will be reviewed by the research team (Principal Investigator and Co-Investigators).

Locations